GlassScriptPhysician profile
Randy James Ip
NPI 1023496957
$4,759.67
in general payments reported to CMS, 2019-2025
20 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $564 · 2021: $544 · 2022: $1,088 · 2023: $749 · 2024: $429 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,493.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $933.92 | 2019-2025 | Assurity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $734.36 | 2019-2023 | Lifevest |
| Abiomed | $668.13 | 2020-2025 | |
| Amgen INC. | $598.19 | 2022-2024 | Repatha |
| Cvrx, INC. | $274.68 | 2023 | Barostim Neo System |
| Heartflow, INC. | $240.26 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $237.68 | 2019 | |
| Boston Scientific Corporation | $193.01 | 2020-2025 | Watchman Access System, Watchman Flx |
| Preventice Services, LLC | $186.88 | 2019 | |
| Atricure, INC. | $155.76 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $137.00 | 2019-2021 | |
| Esperion Therapeutics, INC. | $107.38 | 2021 | |
| Novo Nordisk INC | $100.00 | 2021 | |
| Philips North America LLC | $75.71 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Medtronic, INC. | $38.59 | 2024 | Reveal Linq |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $21.83 | 2024 | Manta |
| Janssen Pharmaceuticals, INC | $17.71 | 2019 | |
| Lantheus Medical Imaging, INC. | $14.32 | 2023 | Definity |
| Edwards Lifesciences Corporation | $12.48 | 2020 | |
| Pfizer INC. | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Ip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.